Valerio Therapeutics Société anonyme

DB:C4X Stock Report

Market Cap: €11.7m

Valerio Therapeutics Société anonyme Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Julien Miara

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownershipn/a
Management average tenure1.8yrs
Board average tenure3.6yrs

Recent management updates

Recent updates

CEO

Julien Miara (41 yo)

less than a year

Tenure

Mr. Julien Miara serves as Chief Executive Officer and Chairman of the Board of Valerio Therapeutics S.A. since November 13, 2024. He serves as Managing Director of Public Equity of The Invus Group, LLC si...

Leadership Team

NamePositionTenureCompensationOwnership
Julien Miara
CEO & Chairmanless than a yearno datano data
Shefali Agarwal
President3.4yrsno datano data
Joyce Carey
Executive Director of Finance and Head of FP&A1.8yrsno datano data
Robin Sutherland
VP & Global Head of Human Resources1.9yrsno datano data
Michel Forest
Chief Pharmacist & Quality Assurance Directorno datano datano data
Huiping Jiang
Senior Vice President of Regulatory Affairs & Quality Assurance2.3yrsno datano data
Wael Jdey
Head of Preclinical1.8yrsno datano data
Donna Cabral-Lilly
VP & Head of CMC1.8yrsno datano data
Pam Slatcher
Head of Global PV1.6yrsno datano data

1.8yrs

Average Tenure

Experienced Management: C4X's management team is not considered experienced ( 1.8 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Julien Miara
CEO & Chairman4.3yrsno datano data
Jacques Mallet
Independent Director3.2yrsno datano data
Khalil Barrage
Representative Director2.5yrsno datano data
Nicolas Trebouta
Representative Director13.5yrsno datano data
Ruth Plummer
Member of Scientific Advisory Committee3.6yrsno datano data
Bryan Giraudo
Independent Director3.1yrsno datano data
Robert Coleman
Independent Director3.2yrsno datano data
Gilbert Chu
Member of Scientific Advisory Committee3.6yrsno datano data
Gilles Favre
Member of Scientific Advisory Committee3.6yrsno datano data
Lorenzo Galluzzi
Member of Scientific Advisory Committee3.6yrsno datano data
Caroline Robert
Member of Scientific Advisory Committee3.6yrsno datano data

3.6yrs

Average Tenure

60yo

Average Age

Experienced Board: C4X's board of directors are considered experienced (3.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 17:55
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Valerio Therapeutics Société anonyme is covered by 6 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Stéphan DubosqArkeon Finance
Eric Le BerrigaudBryan Garnier & Co
Arsene GuekamCIC Market Solutions (ESN)